Elimination of the paper package insert will help get prescription drug products to market faster, maintains a Pharmaceutical Manufacturers & Research of America Paperless Labeling Task Force position paper.
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Already a subscriber?
A draft international guideline on using adaptive trial designs says sponsors should provide a clear rationale for using such designs to address the potential ‘tension’ between the confirmatory nature of late-stage trials and the flexibility introduced by mid-trial adaptations.
Newly introduced rules for streamlining drug registration in Vietnam are said to present both opportunities and challenges for stakeholders.
At Medicines for Europe’s legal and annual conferences in Brussels last week, multiple key issues competed for attention, giving the generics and biosimilars industry plenty to think about at a critical time for EU pharma reform.
